CRISISS: A Novel, Transcriptionally and Post-Translationally Inducible CRISPR/Cas9-Based Cellular Suicide Switch
With the ever-increasing developing rate of gene and cellular therapy applications and growing accessibility due to products receiving regulatory approval, the need for effective and reliable safety mechanisms to prevent or eliminate potentially fatal side effects is of the utmost importance. In thi...
Main Authors: | Maximilian Amberger, Esther Grueso, Zoltán Ivics |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/12/9799 |
Similar Items
-
CRISPR-to-Kill (C2K)–Employing the Bacterial Immune System to Kill Cancer Cells
by: Dawid Głów, et al.
Published: (2021-12-01) -
CRISPR deletion of a SINE-VNTR-Alu (SVA_67) retrotransposon demonstrates its ability to differentially modulate gene expression at the MAPT locus
by: Alexander Fröhlich, et al.
Published: (2023-09-01) -
Exploring the Interplay of the CRISPR-CAS System with Antibiotic Resistance in <i>Staphylococcus aureus</i>: A Poultry Meat Study from Lahore, Pakistan
by: Muhammad Abu Bakr Shabbir, et al.
Published: (2024-01-01) -
Genome Editing in Bacteria: CRISPR-Cas and Beyond
by: Ruben D. Arroyo-Olarte, et al.
Published: (2021-04-01) -
Reprogramming the endogenous type I CRISPR‐Cas system for simultaneous gene regulation and editing in Haloarcula hispanica
by: Kaixin Du, et al.
Published: (2022-03-01)